Reinsurance in Germany Forecast, and Opportunity Assessment 2020


Reinsurance in Germany
 Synopsis
Timetric’s 'Reinsurance in Germany, Key Trends and Opportunities to 2020' report provides detailed analysis of the trends, drivers and challenges in the German reinsurance segment. It provides values for key performance indicators such as written premium, reinsurance ceded and reinsurance accepted during the review period (2011–2015) and forecast period (2015–2020).
The report also analyses information pertaining to the competitive landscape in the country, gives a comprehensive overview of the German economy and demographics, and provides detailed analysis of natural hazards and their impact on the German insurance industry.
The report brings together Timetric’s research, modeling and analysis expertise to enable reinsurers to identify segment dynamics and competitive advantages, and access profiles of reinsurers operating in the country.
Click here for sample report @http://www.wiseguyreports.com/sample-request/1643818-reinsurance-in-germany-key-trends-and-opportunities-to-2020
Summary
Timetric’s 'Reinsurance in Germany, Key Trends and Opportunities to 2020' report provides in-depth market analysis, information and insights into the German reinsurance segment, including:
• The German reinsurance segment’s growth prospects by reinsurance ceded from direct insurance
• A comprehensive overview of the German economy and demographics
• Detailed analysis of natural hazards and their impact on the German insurance industry
• The competitive landscape in the German reinsurance segment
Scope
This report provides a comprehensive analysis of the reinsurance segment in Germany:
• It provides historical values for the German reinsurance segment for the report’s 2011–2015 review period, and projected figures for the 2015–2020 forecast period.
• It offers a detailed analysis of the key categories in the German reinsurance segment, and market forecasts to 2020.
• It provides a detailed analysis of the reinsurance ceded from various direct insurance segments in Germany, and the reinsurance segment's growth prospects.
Reasons To Buy
• Make strategic business decisions using in-depth historic and forecast market data related to the German reinsurance segment, and each category within it.
• Understand the demand-side dynamics, key market trends and growth opportunities in the German reinsurance segment.
• Identify growth opportunities and market dynamics in key product categories.
• Gain insights into key regulations governing the German insurance industry, and their impact on companies and the industry's future.
Key Highlights
• On April 27, 2017, BaFin, the German financial regulatory authority, published Circular No. 4/2017 regarding amendments to the use of internal models for solvency calculation for insurance and reinsurance companies.
• On February 2, 2017, the European Parliament and European Council published a new Insurance Distribution Directive 2016/97 in the official journal of the European Union (EU). The directive came into effect on February 23, 2017, and repealed directive 2002/92/EC. The main objective is to create a legislative framework for the distribution of insurance and reinsurance products in the EU, with the aim of facilitating fair competition and enhancing consumer protection.
• On January 13, 2017, US and EU negotiators agreed insurance and reinsurance regulations regarding domestic insurers operating in other markets.
• On August 31, 2016, an interpretative decision stipulating provisions for non-EU or non-European Economic Area (EEA) countries carrying out reinsurance was published.
Table of Contents                                                                                                                

1 Key Facts and Highlights
2 Executive Summary
3 Economy and Demographics
4 Reinsurance outlook
    4.1 Reinsurance Segment Size, 2011–2020
      4.1.1 Total reinsurance premium accepted
      4.1.2 Reinsurance premium accepted by category
    4.2 Reinsurance Segment Size by Premium Ceded, 2011–2020
5 Natural and Man-made Hazards
    5.1 Windstorms and Hailstorms
    5.2 Floods
    5.3 Extreme Temperature and Drought
    5.4 Exposure
6 Competitive Landscape 
For Detailed Reading Please visit @https://www.wiseguyreports.com/reports/1643818-reinsurance-in-germany-key-trends-and-opportunities-to-2020
About Us                                                                           
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Comments

Post a Comment

Popular posts from this blog

Hypotension Treatment Market 2018 – 2023 Projected to Grow Radiantly by Top Players Revenue and Growth Rate

Market Overview: Hypotension refers to very low blood pressure and affects people across all age groups. Blood pressure is the force exerted by human blood against the artery walls, while blood is pumped out by the heart. Hypotension is normally characterized by a diastolic pressure that is lower than 60mm Hg. A systolic pressure lower than 90 mm Hg is also typically symptomatic of hypotension. The global hypotension market is propelled by hypotension incidences, diabetes, cardiovascular disorders, and other health issues. When patients suffer from low blood pressure or hypotension, they may feel dizziness while standing up after sitting for long periods of time. This is why, many of them are advised to not rise suddenly and take support/more time to stand up without any discomfort. Hypotension can also result from dehydration, nervous disorders, and endocrine issues. The geriatric population is quite susceptible to suffering from low blood pressure, boosting the rates of hosp...
Read more

Hemostasis and Tissue Sealing Agents Market Forecasts by Industry Drivers, Regions Till 2030

  Market Highlights The global  hemostasis and tissue sealing agents market size  is projected to grow at a CAGR of 8.6% over the forecast period. There has been increasing demand for such products as it reduces complication during surgical procedures. Moreover, large number of surgical procedures across the globe are impacting the growth of the market positively. Increasing numbers of surgery procedures worldwide is one of another reason for driving the growth of the hemostasis and tissue sealing agents market.  Surgeries are performed by making cut on the body which leads to the wound formation. Hemostasis and tissue sealing agents products are used in external surgical processes for reducing bleeding. For example, they are used in neurosurgical procedures, cardiac surgery, bariatric surgery, leg surgery, cesarean and orthopedic surgery. Hemostasis and tissue sealing agents products, are frequently used to reduce complexity and reduce recovery time after surgery. T...
Read more

Stem Cell Manufacturing Market Professional Overview 2022-2030 with Major Vendors Size, Shares and Worldwide Demand

  Stem Cell Manufacturing Market - Highlights The Stem Cell Manufacturing Industry is expected to have accounted for the market value of USD 10.8 billion in 2022 and is projected to grow at a Stem Cell Manufacturing Market CAGR of 6.6% over the assessment period. Stem cell manufacturing is a process in which cells from the bone marrow or peripheral blood cells are isolated and cultured in a culture dish containing nutrient media. Rising stem cell related transplants, increasing number of clinical trials for stem cell therapies and growing stem cell research is anticipated to boost the growth of the market during the assessment period. According to a report published by Lozier Institute in November 2022, there are nearly 3,500 ongoing or completed clinical trials (in patients) using adult stem cells, as listed in the National Institutes of Health/FDA-approved database. On the other hand, high costs associated with stem cell research and stringent govern...
Read more